Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ

Journal of Surgical Research

Volumn 173, Issue 1, 2012, Pages 10-15

  Al Mushawah, Fatema ^a   Rastelli, Antonella ^a   Pluard, Timothy ^a   Margenthaler, Julie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DCIS; Her2 neu amplification; metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AXILLARY LYMPH NODE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; CLINICAL ARTICLE; COMEDO; CURATIVE INTENT THERAPY; GENE AMPLIFICATION; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; METASTASIS; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 84857060411     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.058     Document Type: Article

References (44)

1. L.S. Phillips, R.C. Millikan, and J.C. Schroeder Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev 18 2009 1507
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
3. K. Kerlikowske Epidemiology of ductal carcinoma in situ JNCI Monographs 2010 2010;41:139
4. R. Sørum, S. Hofvind, and P. Skaane Trends in incidence of ductal carcinoma in situ: The effect of a population-based screening programme Breast 19 2010 499
5. S. Hofvind, P.M. Vacek, and J. Skelly Comparing screening mammography for early breast cancer detection in Vermont and Norway J Natl Cancer Inst 100 2008 1082
6. M.J. Silverstein, D.N. Poller, and J.R. Waisman Prognostic classification of breast ductal carcinoma in situ Lancet 345 1995 1154
7. B. Fisher, S. Land, and E. Mamounas Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience Semin Oncol 28 2001 400
8. S. Dawood, K. Broglio, and A.M. Gonzalez-Angulo Development of new cancers in patients with DCIS: The M.D. Anderson experience Ann Surg Oncol 15 2008 244
9. J.L. Warren, D.L. Weaver, and T. Bocklage The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: A population based analysis Cancer 104 2005 1840
10. V.L. Ernster, J. Barclay, and K. Kerlikowske Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 2000 953
11. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672
12. B. Fisher, J.P. Costantino, and D.L. Wickerham Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371
13. B. Fisher, J. Dignam, and N. Wolmark Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial Lancet 353 1999 1993
14. J.P. Julien, N. Bijker, and I.S. Fentiman Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group Lancet 355 2000 528
15. V.L. Ernster, J. Barclay, and K. Kerlikowske Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 1996 913
16. G.F. Schwartz, L.J. Solin, and I.A. Olivotto Consensus Conference Committee. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999 Cancer 88 2000 946
17. M. Morrow, L. Venta, and T. Stinson Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients Ann Surg 233 2001 537
18. M.L. Darling, D.N. Smith, and S.C. Lester Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision AJR Am J Roentgenol 175 2000 1341
19. M.J. Silverstein, M.D. Lagios, and A. Recht Image-detected breast cancer: State of the art diagnosis and treatment J Am Coll Surg 201 2005 586
20. L.E. Hoorntje, P.H. Peeters, and W.P. Mali Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat 86 2004 165
21. F.J. Dominguez, M. Golshan, and D.M. Black Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ Ann Surg Oncol 15 2008 268
22. T.W. Yen, K.K. Hunt, and M.I. Ross Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 2005 516
23. L. Liberman Clinical management issues in percutaneous core breast biopsy Radiol Clin North Am 38 2000 791
24. L. Liberman, M. Drotman, and E.A. Morris Imaging-histologic discordance at percutaneous breast biopsy Cancer 89 2000 2538
25. R.J. Jackman, F. Burbank, and S.H. Parker Stereotactic breast biopsy of nonpalpable lesions: Determinants of ductal carcinoma in situ underestimation rates Radiology 218 2001 497
26. R.J. Jackman, K.W. Nowels, and J. Rodriguez-Soto Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up Radiology 210 1999 799
27. L.E. Hoorntje, M.E. Schipper, and P.H. Peeters The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma in situ: Causes of ductal carcinoma in situ underestimates with stereotactic 14-gauge needle biopsy Ann Surg Oncol 10 2003 748
28. S. Pendas, E. Dauway, and R. Giuliano Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol 7 2000 15
29. M.J. Silverstein, E.D. Gierson, and J.R. Waisman Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 73 1994 664
30. P. Veronesi, M. Intra, and A.R. Vento Sentinel lymph node biopsy for localized ductal carcinoma in situ? Breast 14 2005 520
31. T.A. Kelly, J.A. Kim, and R. Patrick Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ Am J Surg 186 2003 368
32. S. Pendas, J. Jakub, and R. Giuliano The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy Cancer Control 11 2004 231
33. D.J. Winchester, H.R. Menck, and D.P. Winchester The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy Cancer 80 1997 162
34. D.J. Winchester, H.R. Menck, and D.P. Winchester National treatment trends for ductal carcinoma in situ of the breast Arch Surg 132 1997 660
35. D.P. Winchester, H.R. Menck, and R.T. Osteen Treatment trends for ductal carcinoma in situ of the breast Ann Surg Oncol 2 1995 207
36. D.P. Winchester, R.T. Osteen, and H.R. Menck The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age Cancer 78 1996 1838
37. C. Dunne, J.P. Burke, and M. Morrow Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ J Clin Oncol 27 2009 1615
38. N. Bijker, J.L. Peterse, and L. Duchateau Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 19 2001 2263
39. J. Houghton, W.D. George, and J. Cuzick Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomized controlled trial Lancet 362 2003 95
40. A. Goodwin, S. Parker, and D. Ghersi Postoperative radiotherapy for ductal carcinoma in situ of the breast - a systematic review of the randomised trials Breast 18 2009 143
41. N.N. Baxter, B.A. Virnig, and S.B. Durham Trends in the treatment of ductal carcinoma in situ of the breast J Natl Cancer Inst 96 2004 443
42. A.J. Spiegel, and C.E. Butler Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction Plast Reconstr Surg 111 2003 706
43. L.W. Chan, J. Rabban, and E.S. Hwang Is radiation indicated in patients with DCIS and close/positive mastectomy margins? Int J Radiat Oncol Biol Phys 72 2008 S151
44. R.E. Roses, E.C. Paulson, and A. Sharma HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer Cancer Epidemiol Biomarkers Prev 18 2009 1386